Two Sigma Advisers’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,600
| Closed | -$1.85M | – | 2832 |
|
|
2021
Q1 | $1.85M | Sell |
15,600
-111,900
| -88% | -$13.2M | 0.01% | 1304 |
|
|
2020
Q4 | $15.1M | Buy |
127,500
+122,500
| +2,450% | +$14.2M | 0.04% | 422 |
|
|
2020
Q3 | $556K | Sell |
5,000
-3,200
| -39% | -$344K | ﹤0.01% | 1773 |
|
|
2020
Q2 | $838K | Buy |
8,200
+2,400
| +41% | +$257K | ﹤0.01% | 1668 |
|
|
2020
Q1 | $626K | Buy |
+5,800
| New | +$666K | ﹤0.01% | 1707 |
|
|
2017
Q3 | – | Sell |
-7,100
| Closed | -$803K | – | 2459 |
|
|
2017
Q2 | $803K | Sell |
7,100
-1,800
| -20% | -$201K | ﹤0.01% | 1620 |
|
|
2017
Q1 | $891K | Buy |
+8,900
| New | +$951K | ﹤0.01% | 1642 |
|
|
2016
Q4 | – | Sell |
-16,400
| Closed | -$2.04M | – | 2519 |
|
|
2016
Q3 | $2.04M | Sell |
16,400
-6,700
| -29% | -$791K | 0.01% | 1011 |
|
|
2016
Q2 | $2.46M | Sell |
23,100
-45,400
| -66% | -$5.27M | 0.01% | 789 |
|
|
2016
Q1 | $7.84M | Sell |
68,500
-2,095
| -3% | -$246K | 0.04% | 389 |
|
|
2015
Q4 | $10.1M | Sell |
70,595
-18,805
| -21% | -$2.17M | 0.06% | 319 |
|
|
2015
Q3 | $8.05M | Buy |
89,400
+49,800
| +126% | +$5.26M | 0.05% | 375 |
|
|
2015
Q2 | $4.56M | Sell |
39,600
-3,600
| -8% | -$378K | 0.03% | 512 |
|
|
2015
Q1 | $4.13M | Buy |
43,200
+24,000
| +125% | +$1.8M | 0.03% | 539 |
|
|
2014
Q4 | $1.29M | Buy |
19,200
+1,400
| +8% | +$86.8K | 0.01% | 1031 |
|
|
2014
Q3 | $960K | Buy |
+17,800
| New | +$876K | 0.01% | 1146 |
|
Two Sigma Advisers's CBPO Position: Q2 2021 in Review
Two Sigma Advisers sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 15,600 shares — an estimated $1.85M sold.
Two Sigma Advisers first reported a position in CBPO in Q3 2014 and held it in 16 quarters. The position peaked at $15.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Two Sigma Advisers reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Two Sigma Advisers sold 15,600 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.85M.
- Two Sigma Advisers first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 16 quarters.
- Two Sigma Advisers's China Biologic Products Holdings, Inc. position peaked at $15.1M in Q4 2020.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.